BE870987A - Nouveaux derives du benzo (d) thiazole, leur procede de preparation et leurs applications en therapeutique - Google Patents
Nouveaux derives du benzo (d) thiazole, leur procede de preparation et leurs applications en therapeutiqueInfo
- Publication number
- BE870987A BE870987A BE190888A BE190888A BE870987A BE 870987 A BE870987 A BE 870987A BE 190888 A BE190888 A BE 190888A BE 190888 A BE190888 A BE 190888A BE 870987 A BE870987 A BE 870987A
- Authority
- BE
- Belgium
- Prior art keywords
- preparation process
- therapeutic applications
- thiazole derivatives
- new benzo
- benzo
- Prior art date
Links
- IOJUPLGTWVMSFF-UHFFFAOYSA-N benzothiazole Chemical class C1=CC=C2SC=NC2=C1 IOJUPLGTWVMSFF-UHFFFAOYSA-N 0.000 title 1
- 238000002360 preparation method Methods 0.000 title 1
- 230000001225 therapeutic effect Effects 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
- C07D277/60—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings condensed with carbocyclic rings or ring systems
- C07D277/62—Benzothiazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/26—Psychostimulants, e.g. nicotine, cocaine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/02—Non-specific cardiovascular stimulants, e.g. drugs for syncope, antihypotensives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
- C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
- C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D277/22—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
- C07D277/30—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
- C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
- C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D277/32—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D277/56—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Engineering & Computer Science (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Biomedical Technology (AREA)
- Pain & Pain Management (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Diabetes (AREA)
- Psychiatry (AREA)
- Obesity (AREA)
- Hematology (AREA)
- Child & Adolescent Psychology (AREA)
- Rheumatology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Thiazole And Isothizaole Compounds (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR7731891A FR2406635A1 (fr) | 1977-10-24 | 1977-10-24 | Nouveaux derives du benzo(d)thiazole, leur procede de preparation et leurs applications en therapeutique |
Publications (1)
Publication Number | Publication Date |
---|---|
BE870987A true BE870987A (fr) | 1979-04-03 |
Family
ID=9196842
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BE190888A BE870987A (fr) | 1977-10-24 | 1978-10-03 | Nouveaux derives du benzo (d) thiazole, leur procede de preparation et leurs applications en therapeutique |
Country Status (10)
Country | Link |
---|---|
US (1) | US4208420A (xx) |
JP (1) | JPS5948831B2 (xx) |
BE (1) | BE870987A (xx) |
CH (1) | CH634311A5 (xx) |
DE (1) | DE2845857C2 (xx) |
ES (1) | ES474367A1 (xx) |
FR (1) | FR2406635A1 (xx) |
GB (1) | GB2007232B (xx) |
HU (1) | HU175783B (xx) |
IT (1) | IT1157385B (xx) |
Families Citing this family (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2459239A1 (fr) * | 1979-06-20 | 1981-01-09 | Logeais Labor Jacques | Nouveaux derives amines du benzothiazole, leur procede de preparation et leur application en therapeutique |
EP0186087B1 (de) * | 1984-12-22 | 1989-08-23 | Dr. Karl Thomae GmbH | Tetrahydro-benzthiazole, deren Herstellung und deren Verwendung als Zwischenprodukte oder als Arnzneimittel |
DE3620813A1 (de) | 1986-06-21 | 1987-12-23 | Boehringer Ingelheim Kg | Neue tetrahydro-benzothiazole, ihre herstellung und verwendung |
FR2731619A1 (fr) * | 1995-03-14 | 1996-09-20 | Logeais Labor Jacques | Compositions pharmaceutiques contenant de la l-etrabamine, leurs utilisations et leurs procedes de preparation |
DE19908539A1 (de) * | 1999-02-26 | 2000-08-31 | Aventis Pharma Gmbh | Polycyclische 2-Amino-Dihydrothiazolsysteme, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel |
WO2008001200A2 (en) * | 2006-06-29 | 2008-01-03 | Antares Pharma Ipl Ag | Transdermal composition having enhanced color stability |
WO2014115078A1 (en) * | 2013-01-22 | 2014-07-31 | Actelion Pharmaceuticals Ltd | Heterocyclic amide derivatives as p2x7 receptor antagonists |
EP2956135B1 (en) * | 2013-01-22 | 2016-11-16 | Actelion Pharmaceuticals Ltd. | Heterocyclic amide derivatives as p2x7 receptor antagonists |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB497659A (en) * | 1936-07-29 | 1938-12-22 | Ig Farbenindustrie Ag | Manufacture of 2-alkyl-tetrahydrobenzselenazoles |
US2882160A (en) * | 1955-05-10 | 1959-04-14 | Sperry Rand Corp | Sensitizing dyes from 2-methyl-5, 6-dihydro-4-cyclopentathiazoles |
FR2035757A1 (en) * | 1969-02-25 | 1970-12-24 | Roussel Uclaf | Novel 4-carboxy-4,5,6,7-tetrahydro benzothia- - zole derivs |
-
1977
- 1977-10-24 FR FR7731891A patent/FR2406635A1/fr active Granted
-
1978
- 1978-10-03 BE BE190888A patent/BE870987A/xx not_active IP Right Cessation
- 1978-10-10 GB GB7839983A patent/GB2007232B/en not_active Expired
- 1978-10-11 US US05/950,394 patent/US4208420A/en not_active Expired - Lifetime
- 1978-10-20 IT IT51589/78A patent/IT1157385B/it active
- 1978-10-20 ES ES474367A patent/ES474367A1/es not_active Expired
- 1978-10-21 DE DE2845857A patent/DE2845857C2/de not_active Expired
- 1978-10-23 CH CH1095378A patent/CH634311A5/fr not_active IP Right Cessation
- 1978-10-23 HU HU78LO427A patent/HU175783B/hu not_active IP Right Cessation
- 1978-10-23 JP JP53130366A patent/JPS5948831B2/ja not_active Expired
Also Published As
Publication number | Publication date |
---|---|
FR2406635B1 (xx) | 1980-06-27 |
GB2007232A (en) | 1979-05-16 |
HU175783B (hu) | 1980-10-28 |
JPS5948831B2 (ja) | 1984-11-29 |
US4208420A (en) | 1980-06-17 |
IT7851589A0 (it) | 1978-10-20 |
DE2845857A1 (de) | 1979-04-26 |
ES474367A1 (es) | 1979-04-16 |
FR2406635A1 (fr) | 1979-05-18 |
JPS5470268A (en) | 1979-06-05 |
IT1157385B (it) | 1987-02-11 |
CH634311A5 (fr) | 1983-01-31 |
GB2007232B (en) | 1982-03-10 |
DE2845857C2 (de) | 1982-10-28 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
BE875174A (fr) | Nouveaux derives de carbostyrile, leur procede de preparation et leurs applications en therapeutique | |
BE865632A (fr) | Nouveaux derives de cephalosporine, leur procede de preparation et leur application en therapeutique | |
FR2383157B1 (fr) | Derives de chalcone, leur procede de preparation et leur application en therapeutique | |
BE867421A (fr) | Derives de mevalonolactone, leur procede de preparation et leur application therapeutique | |
FR2387234B1 (fr) | Derives de cephalosporine, leur procede de preparation et leurs applications en therapeutique | |
LU80081A1 (fr) | Nouvelles hydroxymethyl-5 oxazolidinones-2,leur procede de preparation et leur application therapeutique | |
FR2393795B1 (fr) | Derives de carbostyryle, leur procede de preparation et leurs applications en therapeutique | |
FR2493848B2 (fr) | Nouveaux derives des nor-tropane et granatane, leur procede de preparation et leur application en therapeutique | |
FR2313052A1 (fr) | Nouveaux derives d'isoxazoles, leur procede de preparation et leurs applications | |
BE881134A (fr) | Nouveaux derives du nor-tropane, leur procede de preparation et leur application en therapeutique | |
BE858520A (fr) | Derives de thiazolidine leur procede de preparation leur application en therapeutique | |
LU76848A1 (fr) | Nouveaux hydroxymethyl-5 oxazolidinone-2, leur procede de preparation et leur application therapeutique | |
BE871231A (fr) | Nouveaux derives de dihydropyridine, leur procede de preparation et leur application | |
BE870910A (fr) | Nouveaux derives du pyrrole, leur procede de preparation et leurs applications et therapeutique | |
BE864312A (fr) | Nouveaux derives de la pyrrolidine, leur procede de preparation et leur application en therapeutique | |
FR2321297A1 (fr) | Nouveaux derives de dopamine, leur procede de preparation et leurs applications | |
FR2315925A1 (fr) | Nouveaux derives de 5-benzyle-2-oxazolidone, leur procede de preparation et leur application en therapeutique | |
FR2319345A1 (fr) | Derives de thiazolidine, leur procede de preparation et leur application | |
BE870987A (fr) | Nouveaux derives du benzo (d) thiazole, leur procede de preparation et leurs applications en therapeutique | |
BE866676A (fr) | Derives de bisamidine, leur procede de preparation et leur application therapeutique | |
FR2313063A1 (fr) | Derives de pyrrolotriazolopyrimidine leur procede de preparation et leurs applications en therapeutique | |
BE854812A (fr) | Benzenesulfonylurees, leur procede de preparation et leur application therapeutique | |
FR2317930A1 (fr) | Nouveaux derives d'apovincaminol, leur procede de preparation et leur application | |
BE882270A (fr) | Derives de benzothiazole, leur procede de preparation et leurs applications en therapeutique | |
BE868659A (fr) | Nouveaux derives de benzamidine, leur procede de preparation et leurs applications en therapeutique |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
RE | Patent lapsed |
Owner name: LABORATOIRES JACQUES LOGEAIS Effective date: 19951031 |